Cornerstone Planning Group LLC Landos Biopharma, Inc. Transaction History

Cornerstone Planning Group LLC

  • $322 Billion
  • Q1 2024

A detailed history of Cornerstone Planning Group LLC transactions in Landos Biopharma, Inc. stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 12 shares of LABP stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Previous 12 -0.0%
Holding current value
$0
Previous $44,000 506.82%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
BUY
$3.38 - $4.75 $40 - $57
12 New
12 $44,000

Others Institutions Holding LABP

# of Institutions
1
Shares Held
12
Call Options Held
0
Put Options Held
0
View Full List

About Landos Biopharma, Inc.

LABP Quotes by TradingView
  • Ticker LABP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,254,900
  • Description
  • Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of u...
More about LABP
Track This Portfolio

Track Cornerstone Planning Group LLC Portfolio

Follow Cornerstone Planning Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Planning Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Planning Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email